The primary aim of this research is to compare the efficacy of conservative treatment versus surgical treatment for Gartland type II supracondylar humerus fractures in children. The comparison focuses on assessing differences in clinical outcomes functional recovery times, and complication rates between the two treatment groups.
Supracondylar Humerus Fractures are the most common type of elbow fracture in children, typically occurring between the ages of five and seven. These injuries are critical due to their proximity to major neurovascular structures, making prompt and appropriate management essential to prevent severe complications. The vast majority (approximately 98%) of SCHFs are extension-type injuries, resulting from a fall onto an outstretched hand with the elbow hyperextended. Classification: The Gartland System The classification is based on the degree of displacement of the distal fragment relative to the proximal fragment, as seen on a lateral radiograph. Type I stable, nondisplaced fractures are managed non-operatively. * Treatment: Immobilization in a long-arm cast or splint for 3 to 4 weeks, typically in 90 degrees of flexion, followed by early mobilization . * Goal: Pain control and protection from further displacement. Type II FracturesThese fractures are unstable in extension but maintain some stability due to the intact posterior cortex. Management remains a point of controversy, with both conservative and surgical options being utilized.•Conservative Option: Closed reduction (CR) and casting, often reserved for less displaced or stable Type IIA fractures.•Surgical Option: Closed Reduction and Percutaneous Pinning (CRPP) is the preferred surgical method, especially for unstable Type IIB fractures (those with rotational instability). Type III and IV are highly unstable fractures that require urgent intervention to achieve and maintain reduction . Treatment: Closed Reduction and Percutaneous Pinning (CRPP) is the mainstay of treatment .Open reduction may be necessary if closed reduction fails or if there is a vascular compromise requiring exploration. •Goal: Anatomical reduction and stable fixation to prevent malunion and neurovascular complications.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Closed reduction of Gartland type II supracondylar humeral fracture under appropriate analgesia or anesthesia, followed by immobilization using an above-elbow cast. Patients will undergo regular clinical and radiographic follow-up to monitor fracture alignment, healing, and functional recovery.
surgical treatment vis Closed reduction and percutaneous pinning under general anesthesia. Postoperative care includes clinical and radiographic follow-up to assess fracture healing, alignment, and potential complications.
Functional outcome assessed by Modified Disabilities of the Arm, Shoulder and Hand (QuickDASH) score
Functional outcome will be evaluated using the Modified QuickDASH questionnaire. Scores range from 0 to 100, with higher scores indicating greater disability.
Time frame: 1 year
Elbow flexion range of motion (degrees)
Measured in degrees using a goniometer to assess maximum elbow flexion.
Time frame: 1 month, 3 months, and 6 months post-intervention
Elbow extension range of motion (degrees)
Measured in degrees using a goniometer to assess maximum elbow extension.
Time frame: 1 month, 3 months, and 6 months post-intervention
Pain assessed using Visual Analog Scale (VAS)
Pain is measured on a scale from 0 to 10, where 0 indicates no pain and 10 indicates worst possible pain.
Time frame: 1 month, 3 months, and 6 months post-intervention
Baumann angle (degrees)
Measured on standard anteroposterior elbow radiographs to assess coronal alignment.
Time frame: Immediately post-reduction and at 6 months
Anterior humeral line alignment (normal/abnormal)
Assessed on lateral elbow radiographs to evaluate sagittal alignment.
Time frame: Immediately post-reduction and at 6 months
Loss of reduction (yes/no)
Defined as displacement of fracture fragments on follow-up radiographs.
Time frame: Up to 6 months post-intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Incidence of nerve injury (yes/no)
Includes any documented motor or sensory nerve deficit following treatment.
Time frame: Up to 6 months post-intervention
Incidence of infection (yes/no)
Includes superficial or deep infection related to treatment.
Time frame: Up to 6 months post-intervention